Publishing in the prestigious journal Nature Communications, Moran's latest AMD research points the field away from a liver-produced protein others had identified as a promising therapeutic target.
约翰A. Moran Eye Center’s Sharon Eccles Steele Center for Translational Medicine (SCTM) is connecting the dots between genetics and disease and developing personalized treatments for age-related macular degeneration...
研究ers studying age-related macular degeneration (AMD) have clarified what constitutes genetic risk or protection for the blinding disease, showing that certain forms of protection amount to an "ace in the...
A research team including 约翰一. Moran Eye Center scientists has identified reading ability and reading speed as key measures for evaluating visual decline in patients with dry, late-stage age-related...
A software based on artificial intelligence (AI) developed in collaboration with 约翰一. Moran Eye Center physician-scientists Steffen Schmitz-Valckenberg, MD, and Monika Fleckenstein, MD, could assist age-related macular degeneration (AMD)...
Retinal specialist Steffen Schmitz-Valckenberg, MD, an internationally recognized expert on age-related macular degeneration (AMD), has joined the 约翰一. Moran Eye Center at the University of Utah.
New research from the 约翰一. Moran Eye Center at the University of Utah highlights a little-known phenomenon that can produce vivid yet harmless hallucinations among older adults as America’s...
约翰A. Moran Eye Center at the University of Utah today announced that Voyant Biotherapeutics, 有限责任公司, a company formed out of its Center for Translational Medicine (CTM), 已经签署了...
A University of Utah researcher and ophthalmologist helped confirm important findings from a group of Icelandic scientists who uncovered a rare risk locus for age-related macular degeneration (AMD).
